⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5612155 | 0.78 | ALDH1A1 (0.31) | — | |
| SCHEMBL3763913 | 0.76 | — | — | |
| SCHEMBL1960946 | 0.74 | — | — | |
| SCHEMBL1961286 | 0.71 | — | — | |
| SCHEMBL2185408 | 0.68 | — | — | |
| SCHEMBL1916567 | 0.68 | — | — | |
| SCHEMBL9320738 | 0.67 | TSHR (0.43) | — | |
| SCHEMBL5972611 | 0.65 | — | — | |
| SCHEMBL1165257 | 0.64 | — | — | |
| SCHEMBL461629 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0533243-B1 | Hydantoin and succinimide-substituted spiroindanylcamphorsulfonyl derivatives | MERCK & CO INC (US) | 1997-12-17 | — | — | EP | claimed |
| US-20240170732-A1 | MIXED POLYHALIDE ELECTROLYTES FOR A STATIC BATTERY AND A METHOD FOR FABRICATING A STATIC BATTERY CELL | EOS Energy Technology Holdings, LLC (US) | 2024-05-23 | — | — | US | disclosed |
| WO-2024097835-A1 | MIXED POLYHALIDE ELECTROLYTES FOR A STATIC BATTERY AND A METHOD FOR FABRICATING A STATIC BATTERY CELL | EOS Energy Technology Holdings, LLC (US) | 2024-05-10 | — | — | WO | disclosed |
| US-11942606-B2 | Electrolyte for rechargeable electrochemical cell | EOS Energy Technology Holdings, LLC (US) | 2024-03-26 | — | — | US | disclosed |
| EP-3204977-B1 | ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL | EOS ENERGY TECH HOLDINGS LLC (US) | 2023-12-20 | — | — | EP | disclosed |
| US-20230107407-A1 | NON-HALIDE ZINC ADDITIVES FOR A SECONDARY ZINC HALIDE BATTERY | EOS Energy Technology Holdings, LLC (US) | 2023-04-06 | — | — | US | disclosed |
| US-20210119265-A1 | ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL | EOS ENERGY STORAGE, LLC (US) | 2021-04-22 | — | — | US | disclosed |
| US-10892524-B2 | Electrolyte for rechargeable electrochemical cell | EOS ENERGY STORAGE, LLC (US) | 2021-01-12 | — | — | US | disclosed |
| EP-3204970-B1 | ELECTOLYTE COMPOSITION FOR A ZINC-HALIDE BATTERY AND BIPOLAR ELECTRODE COMPRISING A TITANIUM CARBIDE COATED CATHODE BOX. | EOS ENERGY STORAGE LLC (US) | 2020-06-10 | — | — | EP | disclosed |
| US-20190198881-A1 | ELECTROLYTE FOR RECHARGEABLE ELECTROCHEMICAL CELL | EOS ENERGY STORAGE LLC | 2019-06-27 | — | — | US | disclosed |
| EP-1781288-A2 | MODULATORS OF MUSCARINIC RECEPTORS | Vertex Pharmaceuticals Incorporated (US) | 2007-05-09 | — | — | EP | disclosed |
| US-7196104-B2 | Thiazolyl urea compounds and methods of uses | AMGEN, INC. (US) | 2007-03-27 | — | — | US | disclosed |
| US-20060160817-A1 | Ion channel modulators and methods of use | VERTEX PHARMACEUTICALS INCORPORATED | 2006-07-20 | — | — | US | disclosed |
| WO-2006050476-A2 | PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2006-05-11 | — | — | WO | disclosed |
| US-20060079505-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS, INCORPORATED (US) | 2006-04-13 | — | — | US | disclosed |
| WO-2006023852-A2 | MODULATORS OF MUSCARINIC RECEPTORS | VERTEX PHARMACEUTICALS, INCORPORATED (US) | 2006-03-02 | — | — | WO | disclosed |
| US-20040044044-A1 | Thiazolyl urea compounds and methods of uses | AMGEN INC. | 2004-03-04 | — | — | US | disclosed |
| US-20040039029-A1 | Thiazolyl urea compounds and methods of uses | AMGEN INC. | 2004-02-26 | — | — | US | disclosed |
| US-6645990-B2 | For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases | AMGEN INC. | 2003-11-11 | — | — | US | disclosed |
| US-20020193405-A1 | Thiazolyl urea compounds and methods of uses | AMGEN INC. | 2002-12-19 | — | — | US | disclosed |